Figure 3
From: A phase 1 trial of nebulised heparin in acute lung injury
Changes in alveolar dead space fraction with nebulised heparin dosage. Percentage change from baseline in the alveolar dead space fraction (ADSF) (mean ± standard deviation).
Figure 3 | Critical Care